Monopar Announces Presentation Selected for 2022 American Society of Hematology (ASH) 64th Annual Meeting

2 years ago

WILMETTE, Ill., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary…

NeoChord Announces Positive 1-year Follow-Up Data with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor

2 years ago

ST. LOUIS PARK, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company, is leading the…

Cocrystal Pharma to Present at the LD Micro Main Event XV

2 years ago

BOTHELL, Wash., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-interim CEO Sam…

Simply Better Brands Corp, Growing 359% vs Year Ago Preliminarily Sales Results Year to Date, Announces Its Trubar Brand’s Accelerated Expansion of Its Portfolio and Distribution

2 years ago

Women-founded, Women-led Nutrition Brand Expands Dessert-inspired, Plant-Based brand in flavor innovation, category expansion and retail footprint TRUBAR 2021 vs 2022…

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Presents Efficacy and Safety Data from Landmark Phase 3 ATTACK Trial at IDWEEK 2022

2 years ago

--- Presentations Reinforce Topline Safety and Efficacy Findings and Highlight Consistency between Clinical and Microbiological EndpointsWALTHAM, Mass., Oct. 19, 2022…

Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio

2 years ago

Brings total to twelve granted patents across the Company’s full portfolio LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma…

Nephros Third Quarter 2022 Financial Results Conference Call

2 years ago

SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology…

Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022

2 years ago

Highlighting Ocugen research and innovative technologies Featuring thought leaders in gene therapy and vaccines MALVERN, Pa., Oct. 19, 2022 (GLOBE…

Abeona Therapeutics Announces Database Lock for Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

2 years ago

NEW YORK and CLEVELAND, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the database lock…

Sinaptica Therapeutics Announces FDA Breakthrough Device Designation for its Novel Noninvasive Neurostimulation Treatment for Alzheimer’s Disease

2 years ago

SinaptiStim™ – AD System provides personalized and precision-delivered electromagnetic therapeutic approach to treating cognitive and functional decline in Alzheimer’s disease…